Purpose

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

For the first 200 patients in the registry, consecutive patients are entered in the registry if they are ≥ 18 years of age, underwent coronary angiography for a STEMI or NSTEMI, and received cangrelor at any time during the hospitalization or an oral P2Y12 inhibitor during his/her first 48 hours of the hospitalization for MI.

Exclusion Criteria

Subsequent patients are eligible to be entered in the registry if they are ≥ 18 years of age and underwent coronary angiography for a STEMI or NSTEMI and meet at least 1 of the following criteria:

The patient was hospitalized for STEMI and met one of the following inclusion criteria:

- The patient received cangrelor at any time during his/her hospitalization for MI.

- The patient received an oral P2Y12 inhibitor during his/her first 48 hours of hospitalization AND either of the following:

- The patient received a P2Y12 inhibitor and an opiate/opioid within 24 hours prior to or during primary PCI for STEMI presentation.

- The patient underwent coronary angiography followed by CABG during the index MI admission and received any P2Y12 inhibitor within 7 days prior to CABG.

The patient was hospitalized for NSTEMI and met one of the following inclusion criteria:

- The patient received cangrelor during his/her hospitalization for MI.

- The patient received an oral P2Y12 inhibitor during his/her first 48 hours of hospitalization.

- The patient underwent coronary angiography followed by CABG during the index MI admission and received any P2Y12 inhibitor within 7 days prior to CABG.

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
STEMI/NSTEMI Patients in the registry will be 18 years of age or older and underwent coronary angiography for a ST-evelvation myocardial infarction (STEMI) or NSTEMI Non-ST-evelvation myocardial infarction

Recruiting Locations

MedStar Health Research Institute, Inc.
Hyattsville, Maryland 20782
Contact:
Syed Ali

More Details

Status
Recruiting
Sponsor
Duke University

Study Contact

Tracy Hofmann
919-668-7544
tracy.hofmann@duke.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.